In today’s recent session, 1.35 million shares of the Teladoc Health Inc (NYSE:TDOC) have been traded, and its beta is 1.82. Most recently the company’s share price was $6.95, and it changed around -$0.2 or -2.73% from the last close, which brings the market valuation of the company to $1.22B. TDOC at last check was trading at a discount to its 52-week high of $15.21, offering almost -118.85% off that amount. The share price’s 52-week low was $6.35, which indicates that the recent value has risen by an impressive 8.63% since then.
Teladoc Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.54. If we narrow it down even further, the data shows that 0 out of 24 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 19 recommended TDOC as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Teladoc Health Inc is expected to report earnings per share of -0.28 for the current quarter.
Teladoc Health Inc (NYSE:TDOC) trade information
Instantly TDOC has been showing red trend so far today with a performance of -2.73% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 7.52 on recent trading dayincreased the stock’s daily price by 7.58%. The company’s shares are currently down -23.49% year-to-date, but still down -5.12% over the last five days. On the other hand, Teladoc Health Inc (NYSE:TDOC) is -4.60% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $13, which translates to bulls needing to increase their stock price by 46.54% from its current value. Analyst projections state that TDOC is forecast to be at a low of $13 and a high of $13.
Teladoc Health Inc (TDOC) estimates and forecasts
The year-over-year growth rate is expected to be -2.10%, down from the previous year.
Consensus estimates provided by 21 financial analysts predict the company will bring in an average of 622.86M in revenue for the current quarter. 21 analysts expect Teladoc Health Inc to make 628.69M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 642.44M and 640.51M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -3.05%. Forecasts for the next quarter put sales growth at -1.84%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -33.66%. Teladoc Health Inc earnings are expected to increase by 81.42% in 2025, but the outlook is positive 46.21% per year for the next five years.
TDOC Dividends
Teladoc Health Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD GROUP INC, with 10.1136% or 17.22 million shares worth $168.38 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 5.25 shares worth $36.6 million, making up 2.99% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 4.56 shares worth around $31.76 million, which represents about 2.60% of the total shares outstanding.
